Stay updated on Triple Therapy Impact on Adherence & Health Status Clinical Trial
Sign up to get notified when there's something new on the Triple Therapy Impact on Adherence & Health Status Clinical Trial page.

Latest updates to the Triple Therapy Impact on Adherence & Health Status Clinical Trial page
- Check2 days agoChange DetectedFooter updates add 'Revision: v3.3.3' and remove 'HHS Vulnerability Disclosure' and 'Revision: v3.3.2'. These are minor site maintenance changes with no impact on the study page; To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check10 days agoNo Change Detected
- Check18 days agoNo Change Detected
- Check25 days agoChange DetectedThe page shows a minor revision update (v3.3.2 added and v3.2.0 removed) that does not affect study content or functionality—To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check32 days agoChange DetectedRemoved a general funding/operating-status notice from the page. The core trial information, eligibility criteria, and outcomes remain unchanged.SummaryDifference0.4%

- Check46 days agoChange DetectedThe new screenshot shows only cosmetic formatting updates with no changes to core study details (eligibility criteria, outcomes, or locations). To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.5%

- Check74 days agoChange Detected- Added a government funding lapse notice and operating-status guidance, plus a version bump to v3.2.0. - Removed the old version reference v3.1.0.SummaryDifference5%

- Check82 days agoChange Detected- Updated revision from v3.0.2 to v3.1.0. This indicates a new version release, but does not imply substantive changes to content.SummaryDifference0.1%

Stay in the know with updates to Triple Therapy Impact on Adherence & Health Status Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Triple Therapy Impact on Adherence & Health Status Clinical Trial page.